Mavyret 40 mg/1

Mavyret 40 mg/1 is a combination medication used to treat certain types of hepatitis C virus (HCV) infections. This oral tablet contains glecaprevir and pibrentasvir, designed for convenient once-daily administration.

Mavyret 40 mg/1 is primarily used for the treatment of chronic hepatitis C virus (HCV) infection. This medication is often prescribed for adults with specific genotypes of HCV, aiming to reduce the viral load in the body. It is important to consult a healthcare provider to determine if Mavyret is suitable for your condition.

Common effects of Mavyret 40 mg/1 may include fatigue, headache, and nausea. Some individuals might experience changes in liver function tests. It is essential to monitor your health and report any persistent or severe symptoms to your healthcare provider.

Mavyret 40 mg/1 should be used with caution in individuals with liver problems or those taking other medications. It is crucial to inform your healthcare provider about all your medical conditions and current medications before starting Mavyret. Always follow the prescribed dosage and administration instructions.

Mavyret 40 mg/1 may interact with certain medications, including those metabolized by the liver enzymes CYP3A or CYP2D6. It is important to avoid alcohol and other substances that can affect liver function. Always consult your healthcare provider before starting or stopping any medications while taking Mavyret.